Sign In
Buy HTGC
Hercules Capital Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.470 |
| EPS actual | $0.480 |
| EPS Surprise | 2.13% |
| Revenue estimate | 141.392M |
| Revenue actual | 141.536M |
| Revenue Surprise | 0.102% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.480 |
| EPS actual | $0.480 |
| Revenue estimate | 141.519M |
| Revenue actual | 137.4M |
| Revenue Surprise | -2.91% |
| Release date | Oct 30, 2025 |
| EPS estimate | $0.480 |
| EPS actual | $0.490 |
| EPS Surprise | 2.08% |
| Revenue estimate | 141.257M |
| Revenue actual | 169.31M |
| Revenue Surprise | 19.86% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.470 |
| EPS actual | $0.500 |
| EPS Surprise | 6.38% |
| Revenue estimate | 136.047M |
| Revenue actual | 79.843M |
| Revenue Surprise | -41.31% |
Last 4 Quarters for Hercules Capital
Below you can see how HTGC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $18.76 |
| EPS estimate | $0.470 |
| EPS actual | $0.500 |
| EPS surprise | 6.38% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $19.44 |
| Jul 28, 2025 | $19.11 |
| Jul 29, 2025 | $19.20 |
| Jul 30, 2025 | $18.91 |
| Jul 31, 2025 | $18.76 |
| Aug 01, 2025 | $19.15 |
| Aug 04, 2025 | $19.36 |
| Aug 05, 2025 | $19.49 |
| Aug 06, 2025 | $19.52 |
| 4 days before | -3.50% |
| 4 days after | 4.05% |
| On release day | 2.08% |
| Change in period | 0.412% |
| Release date | Oct 30, 2025 |
| Price on release | $17.59 |
| EPS estimate | $0.480 |
| EPS actual | $0.490 |
| EPS surprise | 2.08% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $17.62 |
| Oct 27, 2025 | $17.97 |
| Oct 28, 2025 | $18.05 |
| Oct 29, 2025 | $17.75 |
| Oct 30, 2025 | $17.59 |
| Oct 31, 2025 | $17.92 |
| Nov 03, 2025 | $17.81 |
| Nov 04, 2025 | $17.97 |
| Nov 05, 2025 | $18.08 |
| 4 days before | -0.170% |
| 4 days after | 2.79% |
| On release day | 1.88% |
| Change in period | 2.61% |
| Release date | Feb 12, 2026 |
| Price on release | $16.60 |
| EPS estimate | $0.480 |
| EPS actual | $0.480 |
| Date | Price |
|---|---|
| Feb 06, 2026 | $16.45 |
| Feb 09, 2026 | $16.80 |
| Feb 10, 2026 | $16.89 |
| Feb 11, 2026 | $16.79 |
| Feb 12, 2026 | $16.60 |
| Feb 13, 2026 | $15.58 |
| Feb 17, 2026 | $15.84 |
| Feb 18, 2026 | $15.96 |
| Feb 19, 2026 | $15.65 |
| 4 days before | 0.91% |
| 4 days after | -5.72% |
| On release day | -6.14% |
| Change in period | -4.86% |
| Release date | May 05, 2026 |
| Price on release | $16.57 |
| EPS estimate | $0.470 |
| EPS actual | $0.480 |
| EPS surprise | 2.13% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $15.50 |
| Apr 30, 2026 | $16.05 |
| May 01, 2026 | $16.30 |
| May 04, 2026 | $16.44 |
| May 05, 2026 | $16.57 |
| May 06, 2026 | $16.44 |
| May 07, 2026 | $16.40 |
| May 08, 2026 | $16.15 |
| May 11, 2026 | $16.05 |
| 4 days before | 6.90% |
| 4 days after | -3.14% |
| On release day | -0.785% |
| Change in period | 3.55% |
Hercules Capital Earnings Call Transcript Summary of Q1 2026
Hercules Capital reported a strong Q1 2026: record originations of $1.81 billion, record total investment income ($141.5M) and net investment income of $88.1M ($0.48/share). The firm grew assets under management to ~$6.1B (up ~21.8% YoY), increased GAAP leverage to 115.4% to finance growth while maintaining a conservative, credit-first approach, and ended the quarter with robust liquidity (>$1B across the platform; $454.5M available in the BDC). Credit performance remained stable (weighted internal rating 2.11; only one non‑accrual loan representing ~0.2% of cost), first‑lien exposure stayed high (~89%), and PIK as a percent of revenue declined (to ~9.1%) with most PIK coming from original underwriting, not distress. Management expects materially higher Q2 prepayments ($350M–$500M, largely M&A-driven), core yields to remain ~12%–12.5%, and continued disciplined underwriting with emphasis on structure (not chasing yield). The company signaled an offensive posture into market volatility—able to redeploy incoming capital across tech and life sciences—and announced leadership changes (Seth Meyer to President; Andrew Olson named CFO).
